Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Pfizer Inc.    PFE

PFIZER INC.

(PFE)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Health Care Down On Stimulus, Vaccine Doubts -- Health Care Roundup

10/21/2020 | 05:07pm EST

Health-care companies ticked down amid doubts about economic stimulus and coronavirus vaccines.

Drug giant Pfizer has organized what it's calling its "biggest ever" logistics operation to distribute its Covid-19 vaccine once it receives emergency authorization from regulators, The Wall Street Journal reported.

Closely held drug maker Purdue Pharma pleaded guilty to three felonies related to marketing and distribution of opioid painkiller OxyContin, capping yearslong federal investigations into tactics the government said helped fuel the opioid crisis.

The pleas were part of $8.34 billion in settlements with Purdue and its owners, members of the Sackler family.

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

10-21-20 1706ET

All news about PFIZER INC.
08:22aUK appoints vaccines minister to oversee COVID inoculations
AQ
11/27Wall Street Week Ahead: COVID-19 vaccine adoption rates are 'wildcard' for U...
RE
11/27SALESFORCE, DELTA AIR LINES, BEST BU : Stocks That Defined the Week
DJ
11/27PFIZER : A look at what provinces and territories have said about COVID-19 vacci..
AQ
11/27United Begins Flying Pfizer's Covid-19 Vaccine -- Update
DJ
11/27Wall St. gains, Nasdaq hits record high as holiday shopping begins
RE
11/27Ten COVID-19 vaccines seen by mid-year, head of global pharma group says
RE
11/27Vaccine Approval Race Gears Up as U.K. Asks for Emergency Review of AstraZene..
DJ
11/27Wall St rises, Nasdaq hits record high on recovery hopes
RE
11/27Wall St headed higher on recovery hopes after Thanksgiving holiday
RE
More news
Financials (USD)
Sales 2020 49 265 M - -
Net income 2020 19 717 M - -
Net Debt 2020 35 033 M - -
P/E ratio 2020 18,5x
Yield 2020 4,03%
Capitalization 207 B 207 B -
EV / Sales 2020 4,91x
EV / Sales 2021 4,37x
Nbr of Employees 88 300
Free-Float 59,1%
Chart PFIZER INC.
Duration : Period :
Pfizer Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 42,15 $
Last Close Price 37,23 $
Spread / Highest target 47,7%
Spread / Average Target 13,2%
Spread / Lowest Target -5,99%
EPS Revisions
Managers
NameTitle
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Wyllie Don Cornwell Independent Director
Suzanne Nora Johnson Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER INC.0.30%206 939
DAIICHI SANKYO COMPANY, LIMITED56.60%72 682
JIANGSU HENGRUI MEDICINE CO., LTD.17.92%69 850
YUNNAN BAIYAO GROUP CO.,LTD7.23%18 673
ORION OYJ-3.10%6 712
SWEDISH ORPHAN BIOVITRUM AB1.42%5 440